P.2.c.024 PharmacoMRI and cognitive effects of the potential antidepressant AZD6765 compared with ketamine in untreated major depressive disorder

Authors :: Steven Williams
Darragh Downey
Shane McKie
J.F.W. Deakin
G R Dawson
Catherine J. Harmer
Guy M. Goodwin
Colin T. Dourish
Mark A. Smith
Dennis J. McCarthy
Source :: European Neuropsychopharmacology. 22:S264
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Pharmacology
medicine.medical_specialty
business.industry
Cognition
medicine.disease
Psychiatry and Mental health
Neurology
medicine
Major depressive disorder
Antidepressant
Pharmacology (medical)
Ketamine
Neurology (clinical)
Psychiatry
business
Biological Psychiatry
medicine.drug

Full Text Access

Tools